Free shipping on all orders over $ 500

 About 1 result found for searched term "339308-60-0" (0.13 seconds)

Cat.No.  Name Target
M25215 Briakinumab IL Receptor/Related
ABT-874
Briakinumab (ABT-874) is a fully human anti-IL-12/23p40 monoclonal antibody. Briakinumab targets and neutralizes IL-12 and IL-23. Briakinumab can be used for the research of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.